Assignee

Oncternal Therapeutics, Inc.

Patents = 16

Trademarks = 3

Forward Citations = 40

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

22 inventors (with patents filed for the assignee):

Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for the treatment of cancer. The company's pipeline includes targeted oncology drugs designed to selectively inhibit key pathways involved in tumorigenesis. Oncternal Therapeutics aims to improve the lives of cancer patients through innovative and effective treatment options.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com